Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn's disease and ulcerative colitis

Pediatric Research

Volumn 74, Issue 4, 2013, Pages 420-426

  Chouliaras, Giorgos ^a,b   Panayotou, Ioanna ^a   Margoni, Daphne ^a   Mantzou, Emilia ^a   Pervanidou, Panagiota ^a   Manios, Yannis ^c   Chrousos, George P ^a,b   Roma, Eleftheria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c HAROKOPIO UNIVERSITY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINOSALICYLIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOSPORIN; GLUCOCORTICOID; GLUCOSE; IMMUNOMODULATING AGENT; INFLIXIMAB; INSULIN; INTERLEUKIN 6; LEPTIN; MERCAPTOPURINE;

ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CORRELATION COEFFICIENT; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; ENTERIC FEEDING; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; ULCERATIVE COLITIS;

ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE; GREECE; HUMANS; INSULIN; LEPTIN; LINEAR MODELS; MALE; STATISTICS, NONPARAMETRIC;

EID: 84885576350     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.114     Document Type: Article

References (40)

1. Aloi M, Cucchiara S. Extradigestive manifestations of IBD in pediatrics. Eur Rev Med Pharmacol Sci 2009;13:Suppl 1:23-32.
2. Chong SK, Grossman A, Walker-Smith JA, Rees LH. Endocrine dysfunction in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1984;3:529-34. (Pubitemid 14093395)
3. Vortia E, Kay M, Wyllie R. Te role of growth hormone and insulinlike growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients. Curr Opin Pediatr 2011;23:545-51.
4. Stofova A. Leptin and adiponectin: from energy and metabolic dys-balance to infammation and autoimmunity. Endocr Regul 2009;43: 157-68.
5. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010;152:93-100.
6. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002;16:1163-76. (Pubitemid 34815404)
7. Díez JJ, Iglesias P. Te role of the novel adipocyte-derived hormone adipo-nectin in human disease. Eur J Endocrinol 2003;148:293-300. (Pubitemid 36410714)
8. Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V. Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease. Clin Gastroenterol Hepatol 2011;9:684-687.e1.
9. Barbier M, Vidal H, Desreumaux P, et al. Overexpression of leptin mRNA in mesenteric adipose tissue in infammatory bowel diseases. Gastroen-terol Clin Biol 2003;27:987-91. (Pubitemid 37516823)
10. Karmiris K, Koutroubakis IE, Kouroumalis EA. Leptin, adiponectin, resis-tin, and ghrelin-implications for infammatory bowel disease. Mol Nutr Food Res 2008;52:855-66.
11. Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva F F. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab 1997;82:2849-55. (Pubitemid 27385638)
12. Aurangzeb B, Leach ST, Lemberg DA, Day AS. Assessment of nutritional status and serum leptin in children with infammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;52:536-41.
13. Hoppin AG, Kaplan LM, Zurakowski D, Leichtner AM, Bousvaros A. Serum leptin in children and young adults with infammatory bowel disease. J Pediatr Gastroenterol Nutr 1998;26:500-5. (Pubitemid 28183599)
14. Bannerjee K, Camacho-Hübner C, Babinska K, et al. Anti-infamma-tory and growth-stimulating efects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-5.
15. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resis-tin, and ghrelin in infammatory bowel disease. Infamm Bowel Dis 2006;12:100-5.
16. Nishi Y, Isomoto H, Ueno H, et al. Plasma leptin and ghrelin concentrations in patients with Crohn's disease. World J Gastroenterol 2005;11:7314-7. (Pubitemid 43137682)
17. Ballinger A, Kelly P, Hallyburton E, Besser R, Farthing M. Plasma leptin in chronic infammatory bowel disease and HIV: implications for the patho-genesis of anorexia and weight loss. Clin Sci 1998;94:479-83. (Pubitemid 28205911)
18. Valentini L, Wirth EK, Schweizer U, et al. Circulating adipokines and the protective efects of hyperinsulinemia in infammatory bowel disease. Nutrition 2009;25:172-81.
19. Tuzun A, Uygun A, Yesilova Z, et al. Leptin levels in the acute stage of ulcerative colitis. J Gastroenterol Hepatol 2004;19:429-32. (Pubitemid 38570194)
20. Kaser A, Tilg H. "Metabolic aspects" in infammatory bowel diseases. Curr Drug Deliv 2012;9:326-32.
21. Paul G, Schäfer A, Neumeier M, et al. Profling adipocytokine secretion from creeping fat in Crohn's disease. Infamm Bowel Dis 2006;12:471-7.
22. Faggioni R, Jones-Carson J, Reed DA, et al. Leptin-defcient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci USA 2000;97:2367-72. (Pubitemid 30134075)
23. Faggioni R, Fantuzzi G, Fuller J, Dinarello CA, Feingold KR, Grunfeld C. IL-1 beta mediates leptin induction during infammation. Am J Physiol 1998;274(1 Pt 2):R204-8.
24. De Rosa V, Procaccini C, Calì G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007;26:241-55. (Pubitemid 46329441)
25. Sitaraman S, Liu X, Charrier L, et al. Colonic leptin: source of a novel pro-infammatory cytokine involved in IBD. FASEB J 2004;18:696-8.
26. Weigert J, Obermeier F, Neumeier M, et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Infamm Bowel Dis 2010;16:630-7.
27. Yamamoto K, Kiyohara T, Murayama Y, et al. Production of adiponectin, an anti-infammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005;54:789-96. (Pubitemid 40732095)
28. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723-32. (Pubitemid 30661055)
29. Ouchi N, Walsh K. Adiponectin as an anti-infammatory factor. Clin Chim Acta 2007;380:24-30.
30. Capristo E, Mingrone G, Addolorato G, Greco AV, Gasbarrini G. Glucose metabolism and insulin sensitivity in inactive infammatory bowel disease. Aliment Pharmacol Ter 1999;13:209-17. (Pubitemid 29090017)
31. Yorulmaz E, Adali G, Yorulmaz H, Ulasoglu C, Tasan G, Tuncer I. Metabolic syndrome frequency in infammatory bowel diseases. Saudi J Gastro-enterol 2011;17:376-82.
32. Bregenzer N, Hartmann A, Strauch U, Schölmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn's disease. Infamm Bowel Dis 2006;12:53-6. (Pubitemid 43032452)
33. Bendet N, Scapa E, Cohen O, et al. Enhanced glucose-dependent gluca-gon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection. Scand J Gas-troenterol 2004;39:650-6. (Pubitemid 38916241)
34. Paz-Filho G, Wong ML, Licinio J. Ten years of leptin replacement therapy. Obes Rev 2011;12:e315-23.
35. Hashimoto K, Kasayama S, Yamamoto H, Kurebayashi S, Kawase I, Koga M. Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabet Med 2004;21:581-5. (Pubitemid 38746278)
36. IBD working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Infammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41: 1-7.
37. Hyams J, Markowitz J, Otley A, et al.; Pediatric Infammatory Bowel Disease Collaborative Research Group. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastro-enterol Nutr 2005;41:416-21. (Pubitemid 41407602)
38. Turner D, Hyams J, Markowitz J, et al.; Pediatric IBD Collaborative Research Group. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Infamm Bowel Dis 2009;15:1218-23.
39. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95. (Pubitemid 38680001)
40. Manios Y, Moschonis G, Kourlaba G, et al. Prevalence and independent predictors of insulin resistance in children from Crete, Greece: the Children Study. Diabet Med 2008;25:65-72.